The Result of the Phase 3 Study for Prestige BioPharma’s Herceptin Biosimilar, HD201(Tuznue®), Published in JAMA Oncology
SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Limited (950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, announced positive efficacy and...

Oil’s 12% crash is a Washington story, not a supply story
Arsenal beat Slavia Prague 1-0 in Champions League with late own goal
Champions League: Demichelis-led RB Leipzig host Man City in must-win League Phase tie
Cyclone Murasu weakens into well-marked low-pressure area; Andhra counts two dead
Rinky Hijikata beats Novak Djokovic from a set down in Paris Masters Round 2 


















